Gradipore trade halted as director calls for board revamp
Thursday, 29 May, 2003
Trading in shares of Sydney-based company Gradipore were halted this afternoon after one of the company's directors sought to call a shareholder meeting to remove four directors from the board and elect two new ones.
The company is seeking legal advice and would not comment about which director had called the meeting.
Gradipore's directors are executive chairman Prof Jeremy Davis, US-based former CEO Robert Lieb, John Manusu, Dr Perry Manusu and Les Webb.
Lieb officially stepped down from the CEO's position last week after about a year in the job. The company is searching for his replacement.
Two weeks ago the company revised its projected loss for the year from $AUD12 million to $15.5-16 million, attributing the new figure to production cost blowouts and lower than expected sales of its Gradiflow instrument.
At the time of the trading halt, Gradipore's shades were worth $AUD0.83.
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
